Investing.com --Evercore ISI upgraded Hyatt Hotels (NYSE:H) to "outperform" from "in-line" citing an attractive entry point following the stock’s post-earnings selloff and underperformance ...

It has been about a month since the last earnings report for Evercore (EVR). Shares have lost about 26.3% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

In a report released on February 28, Kirk Materne from Evercore ISI maintained a Buy rating on AvePoint (AVPT – Research Report), with a price target of $18.00. The company’s shares closed ...

Evercore ISI analyst Amit Daryanani maintained a Hold rating on Ingram Micro Holding Corporation (INGM – Research Report) yesterday and set a price target of $26.00. The company’s shares ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (BRSE:1CG) from In-Line to Outperform. There are 577 funds or institutions reporting ...

Fortrea stock opened at $10.96 on Tuesday. The stock has a market cap of $983.11 million, a P/E ratio of -3.20, a PEG ratio of 1.78 and a beta of 1.34. The company has a debt-to-equity ratio of 0. ...

Also, Evercore ISI upgrades shares to Outperform from In-Line with a $14 price target, raised from $12, believing the market underappreciates the Hawaii Supreme Court decision that lowers the ...

CRSP stock opened at $49.72 on Friday. The business’s 50-day moving average price is $41.89 and its 200-day moving average price is $46.10. The stock has a market cap of $4.24 billion, a P/E ...

Fintel reports that on March 5, 2025, Evercore ISI Group upgraded their outlook for Hyatt Hotels (NYSE:H) from In-Line to Outperform. As of March 4, 2025, the average one-year price target for ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) from In-Line to Outperform. Analyst Price Forecast Suggests 90.46% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...